Spectral MD Holdings Ltd
LSE:SMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its Industry Average (27.6), the stock would be worth GBX-43.96 (176% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -36.4 | GBX58 |
0%
|
| Industry Average | 27.6 | GBX-43.96 |
-176%
|
| Country Average | 22.9 | GBX-36.44 |
-163%
|
Forward P/E
Today’s price vs future net income
| Today's Market Cap | Net Income | Forward P/E | ||
|---|---|---|---|---|
|
GBX78.5m
|
/ |
Jan 2023
$-2.9m
|
= |
|
|
GBX78.5m
|
/ |
Dec 2023
$-10m
|
= |
|
|
GBX78.5m
|
/ |
Dec 2024
$-2.9m
|
= |
|
|
GBX78.5m
|
/ |
Dec 2025
$14.9m
|
= |
|
Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Spectral MD Holdings Ltd
LSE:SMD
|
78.5m GBP | -36.4 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
161.2B USD | 56.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
157.7B USD | 25.1 | |
| US |
|
Stryker Corp
NYSE:SYK
|
120.5B USD | 37.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
101.9B USD | 22.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
85.4B USD | 24 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.2B USD | 44.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
39.3B EUR | 18.6 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.1B USD | 42.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
42.4B USD | 24.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
30.9B USD | 21 |
Market Distribution
| Min | 0 |
| 30th Percentile | 15.3 |
| Median | 22.9 |
| 70th Percentile | 33.2 |
| Max | 1 826 183.3 |
Other Multiples
Spectral MD Holdings Ltd
Glance View
Spectral MD Holdings Ltd. develops proprietary AI algorithms and optical technology to help clinicians to make faster treatment decisions in wound care sector. The company is headquartered in Dallas, Texas. The company went IPO on 2021-06-22. The firm is focused on developing DeepView wound imaging system. The firm is also providing contract development and research services to the governmental agencies. The firm is offerings its services to the Biomedical Advanced Research and Development Authority (BARDA).
